Theravance, Inc. (NASDAQ:THRX)
CAPS Rating:
A biopharmaceutical company focuses on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections and gastrointestinal motility dysfunction.
RSS Headlines
Fool UK
Recs
Easiest way to find overvalued stocks go thru some biotechs.This one way overpriced Rev 20 Mil shares 60 mil. Insiders selling.Book value $1 . Muahhh look out below.My biotech shorts are outperforming. Get a basket of the worst ones and short.